bluebird bio
BLUE
$0.90
Share price
-0.39%
Change (1 day)
-78.16%
Change (1 year)
bluebird bio (BLUE) Fails to deliver data
Key failure to deliver metrics for bluebird bio :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.15 M
- Last 3 months FTD volume: $6.65 M
- Last year FTD volume: $49.1 M
Failures to deliver for bluebird bio (BLUE) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for bluebird bio (BLUE) - since 2013
Volume in USD (price x number of shares), data since 2013bluebird bio (BLUE) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $7.18 M | -84.06% |
| 2023 | $45.11 M | 1.88% |
| 2022 | $44.28 M | 321.07% |
| 2021 | $10.51 M | -75.61% |
| 2020 | $43.11 M | -71.06% |
| 2019 | $0.14 B | 21.45% |
| 2018 | $0.12 B | 31.09% |
| 2017 | $93.57 M | 18.82% |
| 2016 | $78.74 M | 61.86% |
| 2015 | $48.65 M | 252.68% |
| 2014 | $13.79 M | 14.53% |
| 2013 | $12.04 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Sanofi SNY | $26.39 M | $50.57 M | 🇫🇷 France |
 Merck MRK | $6 M | $0.17 B | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $0.18 M | $1.66 M | 🇺🇸 USA |
 GlycoMimetics
GLYC | $0.15 M | $0.39 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $2.15 M | $7.63 M | 🇺🇸 USA |